Acute Myeloid Leukemia (AML) is a fast-progressing cancer of the blood and bone marrow, characterized by the rapid proliferation of abnormal myeloid cells. Despite advances in treatment, AML remains a significant clinical challenge due to its aggressive nature, high relapse rates, and limited therapeutic options. The global Acute Myeloid Leukemia market is evolving rapidly, driven by...